-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Arcutis Biotherapeutics, Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2023 to Q3 2024.
- Arcutis Biotherapeutics, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $83.8M, a 11.7% increase year-over-year.
- Arcutis Biotherapeutics, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $321M.
- Arcutis Biotherapeutics, Inc. annual Costs and Expenses for 2023 was $301M, a 1.51% decline from 2022.
- Arcutis Biotherapeutics, Inc. annual Costs and Expenses for 2022 was $305M, a 47.8% increase from 2021.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)